©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 112841
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112841
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112841
Table 4 Comparative overview of the outcomes: 90-day mortality
| Pourlotfi et al[9] | Löffler et al[16] | |
| Statin therapy definition | User defined as redeeming 1 or more statin prescriptions 1 year before surgery; postoperative continuation period not stated | Prescribed statins with prescriptions active or in use during the period spanning up to 365 days before surgery |
| Type of surgical data | Rectal cancer only | Colectomy and rectal resection combined and separate |
| Surgical procedure | Anterior resection; abdominoperineal resection Hartmann’s operation | |
| Comorbidities | Diabetes; COPD; liver disease, hypertension; congestive heart failure | |
| Results | Unadjusted (statin n/N) 20/3019, PS matched (statin n/N) 20/3017; unadjusted (non-statin n/N) 291/8947, PS matched (non-statin n/N) 166/3017 | Statin (n/N) 217/3654; non-statin (n/N) 242/3654 |
- Citation: Mohsin S, Hasan M, Mustafa F, Kumar J, Aleissa M, Bhullar JS, Kumar S. Impact of statin therapy on postoperative outcomes following colorectal cancer surgery: A systematic review. World J Gastrointest Surg 2025; 17(12): 112841
- URL: https://www.wjgnet.com/1948-9366/full/v17/i12/112841.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i12.112841